- The trend backdrop is active with a 17-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
HSCL
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Himadri Speciality Chemical Limited · Basic Materials · Specialty Chemicals
Latest close
752.7 INR
0.3%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 31.8% above the Trend Line and sits at 83.4% of its 52-week range. The latest completed week returned 0.3%, after a 14.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 61/100. Near-term considerations: volume confirmation is below normal.
Setup score
67
out of 100
Latest Close
752.7 INR
7 Aug 2026
1W Return
0.3%
latest completed week
4W Return
14.0%
short-term follow-through
12W Return
26.5%
quarterly tape
Trend Breadth
50.0%
26 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- 16 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.3%
Latest completed week; four-week move 14.0%.
Indicator stack
72/76
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
61/100
29 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 31.8% above the Trend Line and sits at 83.4% of its 52-week range. The latest completed week returned 0.3%, after a 14.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9912-week average 0.88
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.99Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1616 reversal markers
No recent accumulation markers. 16 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 14.0% over four weeks, 26.5% over 12 weeks, and 67.7% over one year. The current trend has remained active for 17 consecutive weeks.
Performance by holding period
Active trend streak17 weeks
Active weeks in one year26
Trend breadth50.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.36Latest activity-pressure read.
Pressure change25.9%Four-week change in activity pressure.
Leadership43.64Latest relative-leadership reading.
RS change29.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength37/100Blend of value, momentum, and quality. Underlying universe rank 64; rank 1 is best.
Value12/100Relative valuation strength. Underlying universe rank 89; rank 1 is best.
Quality64/100Profitability and accounting quality. Underlying universe rank 37; rank 1 is best.
Momentum93/100Medium-term price momentum. Underlying universe rank 8; rank 1 is best.
Growth36/100Revenue and earnings growth. Underlying universe rank 65; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework53/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 52.0x Price divided by trailing earnings.
- Price / sales
- 8.0x Market value relative to trailing revenue.
- EV / EBITDA
- 34.8x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -0.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 36.9% Gross profit retained from each unit of revenue.
- Operating margin
- 28.9% Operating profit retained from revenue.
- Free-cash-flow margin
- -1.4% Free cash flow generated from revenue.
- Return on invested capital
- 19.3% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 1.3% Latest one-year revenue growth.
- EPS growth
- 32.3% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -124.5% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.1% Cash dividends relative to market value.
- Buyback yield
- -0.7% Net share repurchases relative to market value.
- Shareholder yield
- -0.6% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.5x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment61/100
Weighted news tone is positive across 29 relevant articles.
8 positive · 20 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.2%Distance below the 52-week high.
13-week volatility5.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+14.7%Week of 24 Apr.
Worst week-6.9%Week of 6 Mar.
Latest week+0.3%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains6
Flat weeks0
Modest losses8
Sharp losses3
Recent vol5.7%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew4.0% / -2.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank8 / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank21 / 100
Group average5.8%
Trend breadth77.0%
Trend77.0%active weekly trend signals
MD75.0%positive activity pressure
RS72.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape64/100
Trend, activity pressure, participation, and risk combine to a 64/100 tape read.
Indicator analysis83/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.99; 16 reversal markers Factors49/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 83 SVQF53/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 744.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment61/100Weighted news tone is positive across 29 relevant articles.
Himadri Speciality Chemical surges to new highs as innovation and earnings fuel investor optimism Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 752.7 INR | 0.3% | 571.3 INR | 451.1 INR | 1.36 | 43.64 | 14.7M | On |
| 31 Jul 2026 | 750.7 INR | -4.9% | 561.8 INR | 447.3 INR | 1.40 | 45.97 | 32.4M | On |
| 24 Jul 2026 | 789.5 INR | 6.5% | 553.3 INR | 443.4 INR | 1.39 | 59.25 | 74.7M | On |
| 17 Jul 2026 | 741.5 INR | 12.3% | 543.0 INR | 439.2 INR | 1.21 | 47.88 | 63.3M | On |
| 10 Jul 2026 | 660.5 INR | -3.0% | 534.2 INR | 435.3 INR | 1.08 | 33.64 | 49.9M | On |
| 3 Jul 2026 | 680.7 INR | 0.4% | 527.7 INR | 432.0 INR | 1.13 | 38.34 | 7.0M | On |
| 26 Jun 2026 | 678.1 INR | 1.1% | 520.9 INR | 428.5 INR | 1.20 | 40.17 | 0 | On |
| 19 Jun 2026 | 671.0 INR | -1.4% | 512.8 INR | 425.0 INR | 1.19 | 40.11 | 13.8M | On |
| 12 Jun 2026 | 680.5 INR | -0.7% | 505.1 INR | 421.5 INR | 1.25 | 45.90 | 16.8M | On |
| 5 Jun 2026 | 685.0 INR | 13.0% | 497.6 INR | 418.0 INR | 1.35 | 49.92 | 24.4M | On |
| 29 May 2026 | 606.5 INR | 3.3% | 489.8 INR | 414.4 INR | 1.51 | 32.94 | 27.6M | On |
| 22 May 2026 | 587.2 INR | -1.4% | 485.7 INR | 411.4 INR | 1.75 | 28.63 | 52.3M | On |
| 15 May 2026 | 595.2 INR | -6.5% | 481.8 INR | 408.4 INR | 1.91 | 31.56 | 60.2M | On |
| 8 May 2026 | 636.8 INR | 4.9% | 477.1 INR | 405.4 INR | 1.77 | 38.60 | 69.7M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.